Tetraethyl orthosilicate | CAS:78-10-4

We serve Tetraethyl orthosilicate CAS:78-10-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Tetraethyl orthosilicate

Chemical Name:Tetraethyl orthosilicate
CAS.NO:78-10-4
Synonyms:ethyl orthosilicate; tetraethyl ortosilicate; tetra-ethyl orthosilicate;
Molecular Formula:C8H20O4Si
Molecular Weight:208.32700
 
Physical and Chemical Properties:
Density:0.94;
Melting point:-77oC;
Boiling point:168oC;
Flash point:46oC;
Index of Refraction:1.382;
 
Specification:
Appearance:Colorless transparent liquid
Purity(GC):≥99.0%
 
Packing:190 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It may be used as an inorganic binder for refractory fillers and pigments, like precision investment castings.
It may be used as a second backup casting coating. It cures faster than colloidal silica system.
It may be hydrolyzed to form silicon dioxide(silica).
It may be used as a binder in zinc-rich (corrosion resistant) coating.
It may be used as a starting material for sol-gel process.
It may be used as a crosslinking agent for silicone sealant.
It may be used as a drying agent in sealing compositions.
It may be used as a chemical intermediate



Contact us for information like Tetraethyl orthosilicate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tetra-ethyl orthosilicate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tetra-ethyl orthosilicate Use and application,tetra-ethyl orthosilicate technical grade,usp/ep/jp grade.


Related News: In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.Methyl isobutyryl acetate manufacturer Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules.5-(4-bromophenyl)-4,6-dichloropyrimidine supplier Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days.N,N,N,N-Tetramethylchloroformamidinium Hexafluorophosphate vendor Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage.Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.